UNCY
Unicycive Therapeutics Inc

3,020
Mkt Cap
$118.63M
Volume
266,676.00
52W High
$11.00
52W Low
$3.71
PE Ratio
-1.74
UNCY Fundamentals
Price
$5.65
Prev Close
$5.52
Open
$5.56
50D MA
$5.57
Beta
0.66
Avg. Volume
350,650.41
EPS (Annual)
-$5.65
P/B
3.14
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Unicycive Resubmits NDA For Oxylanthanum Carbonate To FDA
(RTTNews) - Unicycive Therapeutics, Inc. (UNCY) on Monday said it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration for oxylanthanum carbonate (OLC) for the...
Nasdaq News: Markets·9d ago
News Placeholder
More News
News Placeholder
Vivo Capital LLC Has $5.42 Million Stock Position in Unicycive Therapeutics, Inc. $UNCY
Vivo Capital LLC lowered its position in shares of Unicycive Therapeutics, Inc. (NASDAQ:UNCY - Free Report) by 90.0% in the second quarter, according to its most recent 13F filing with the Securities...
MarketBeat·29d ago
News Placeholder
Unicycive Therapeutics (NASDAQ:UNCY) Trading Up 5.6% - Time to Buy?
Unicycive Therapeutics (NASDAQ:UNCY) Trading 5.6% Higher - Time to Buy...
MarketBeat·29d ago
News Placeholder
UNCY FY2025 EPS Boosted by Brookline Capital Management
Unicycive Therapeutics, Inc. (NASDAQ:UNCY - Free Report) - Research analysts at Brookline Capital Management boosted their FY2025 EPS estimates for Unicycive Therapeutics in a research report issued...
MarketBeat·2mo ago
News Placeholder
HC Wainwright Has Positive Outlook for UNCY FY2029 Earnings
Unicycive Therapeutics, Inc. (NASDAQ:UNCY - Free Report) - Research analysts at HC Wainwright boosted their FY2029 EPS estimates for Unicycive Therapeutics in a research note issued to investors on...
MarketBeat·2mo ago
News Placeholder
Unicycive Therapeutics (NASDAQ:UNCY) Releases Quarterly Earnings Results, Beats Expectations By $0.29 EPS
Unicycive Therapeutics (NASDAQ:UNCY - Get Free Report) announced its quarterly earnings data on Wednesday. The company reported ($0.33) earnings per share for the quarter, beating the consensus...
MarketBeat·2mo ago
News Placeholder
UNCY Deadline Today: Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) between March...
Business Wire·3mo ago
News Placeholder
Unicycive Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - UNCY
Unicycive Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - UNCY Unicycive Therapeutics, Inc. Sued for Securities Law Violations - Contact the...
PR Newswire·3mo ago
News Placeholder
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Unicycive Therapeutics, Inc. (Unicycive or the Company) (NASDAQ: UNCY) and reminds investors of...
Business Wire·3mo ago
News Placeholder
UNCY LAWSUIT ALERT: Levi & Korsinsky Notifies Unicycive Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
UNCY LAWSUIT ALERT: Levi & Korsinsky Notifies Unicycive Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline UNCY LAWSUIT ALERT: Levi & Korsinsky Notifies Unicycive...
PR Newswire·3mo ago
<
1
2
...
>

Latest UNCY News

View

Advertisement|Remove ads.

Advertisement|Remove ads.